0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
COVID-19 Diagnostic Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-0L6183
Home | Market Reports | Science| Engineering & Technology
Global COVID 19 Diagnostic Tests Market Size Status and Forecast 2022 2028
BUY CHAPTERS

COVID-19 Diagnostic Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-0L6183
Report
December 2024
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

COVID-19 Diagnostic Tests - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

COVID-19 Diagnostic Tests - Market

COVID-19 Diagnostic Tests - Market

The global market for COVID-19 Diagnostic Tests was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for COVID-19 Diagnostic Tests, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of COVID-19 Diagnostic Tests by region & country, by Type, and by Application.
The COVID-19 Diagnostic Tests market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Diagnostic Tests.
Market Segmentation

Scope of COVID-19 Diagnostic Tests - Market Report

Report Metric Details
Report Name COVID-19 Diagnostic Tests - Market
CAGR 5%
Segment by Type:
Segment by Application
  • Home
  • Hospital
  • Clinical
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories, Chembio Diagnostics, Mount Sinai Laboratory, Ortho Clinical Diagnostics, Zhejiang Orient Gene Biotech, Innovita Biological Technology, Guangzhou Wondfo Biotech, Guangdong Hecin-Scientific, Dynamiker Biotechnology (Tianjin), ADVAITE
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of COVID-19 Diagnostic Tests manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of COVID-19 Diagnostic Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of COVID-19 Diagnostic Tests in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the COVID-19 Diagnostic Tests - Market report?

Ans: The main players in the COVID-19 Diagnostic Tests - Market are Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories, Chembio Diagnostics, Mount Sinai Laboratory, Ortho Clinical Diagnostics, Zhejiang Orient Gene Biotech, Innovita Biological Technology, Guangzhou Wondfo Biotech, Guangdong Hecin-Scientific, Dynamiker Biotechnology (Tianjin), ADVAITE

What are the Application segmentation covered in the COVID-19 Diagnostic Tests - Market report?

Ans: The Applications covered in the COVID-19 Diagnostic Tests - Market report are Home, Hospital, Clinical

What are the Type segmentation covered in the COVID-19 Diagnostic Tests - Market report?

Ans: The Types covered in the COVID-19 Diagnostic Tests - Market report are Rapid Diagnostic Test (RDT), Enzyme Linked Immunosorbent Assay (ELISA), Neutralization Assay

Recommended Reports

COVID-19 Diagnostics

COVID-19 Vaccines

In Vitro Diagnostics

1 Market Overview
1.1 COVID-19 Diagnostic Tests Product Introduction
1.2 Global COVID-19 Diagnostic Tests Market Size Forecast
1.3 COVID-19 Diagnostic Tests Market Trends & Drivers
1.3.1 COVID-19 Diagnostic Tests Industry Trends
1.3.2 COVID-19 Diagnostic Tests Market Drivers & Opportunity
1.3.3 COVID-19 Diagnostic Tests Market Challenges
1.3.4 COVID-19 Diagnostic Tests Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global COVID-19 Diagnostic Tests Players Revenue Ranking (2023)
2.2 Global COVID-19 Diagnostic Tests Revenue by Company (2019-2024)
2.3 Key Companies COVID-19 Diagnostic Tests Manufacturing Base Distribution and Headquarters
2.4 Key Companies COVID-19 Diagnostic Tests Product Offered
2.5 Key Companies Time to Begin Mass Production of COVID-19 Diagnostic Tests
2.6 COVID-19 Diagnostic Tests Market Competitive Analysis
2.6.1 COVID-19 Diagnostic Tests Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by COVID-19 Diagnostic Tests Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Diagnostic Tests as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Rapid Diagnostic Test (RDT)
3.1.2 Enzyme Linked Immunosorbent Assay (ELISA)
3.1.3 Neutralization Assay
3.2 Global COVID-19 Diagnostic Tests Sales Value by Type
3.2.1 Global COVID-19 Diagnostic Tests Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global COVID-19 Diagnostic Tests Sales Value, by Type (2019-2030)
3.2.3 Global COVID-19 Diagnostic Tests Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Home
4.1.2 Hospital
4.1.3 Clinical
4.2 Global COVID-19 Diagnostic Tests Sales Value by Application
4.2.1 Global COVID-19 Diagnostic Tests Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global COVID-19 Diagnostic Tests Sales Value, by Application (2019-2030)
4.2.3 Global COVID-19 Diagnostic Tests Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global COVID-19 Diagnostic Tests Sales Value by Region
5.1.1 Global COVID-19 Diagnostic Tests Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global COVID-19 Diagnostic Tests Sales Value by Region (2019-2024)
5.1.3 Global COVID-19 Diagnostic Tests Sales Value by Region (2025-2030)
5.1.4 Global COVID-19 Diagnostic Tests Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America COVID-19 Diagnostic Tests Sales Value, 2019-2030
5.2.2 North America COVID-19 Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe COVID-19 Diagnostic Tests Sales Value, 2019-2030
5.3.2 Europe COVID-19 Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific COVID-19 Diagnostic Tests Sales Value, 2019-2030
5.4.2 Asia Pacific COVID-19 Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America COVID-19 Diagnostic Tests Sales Value, 2019-2030
5.5.2 South America COVID-19 Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa COVID-19 Diagnostic Tests Sales Value, 2019-2030
5.6.2 Middle East & Africa COVID-19 Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions COVID-19 Diagnostic Tests Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions COVID-19 Diagnostic Tests Sales Value
6.3 United States
6.3.1 United States COVID-19 Diagnostic Tests Sales Value, 2019-2030
6.3.2 United States COVID-19 Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.3.3 United States COVID-19 Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe COVID-19 Diagnostic Tests Sales Value, 2019-2030
6.4.2 Europe COVID-19 Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe COVID-19 Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China COVID-19 Diagnostic Tests Sales Value, 2019-2030
6.5.2 China COVID-19 Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.5.3 China COVID-19 Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan COVID-19 Diagnostic Tests Sales Value, 2019-2030
6.6.2 Japan COVID-19 Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan COVID-19 Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea COVID-19 Diagnostic Tests Sales Value, 2019-2030
6.7.2 South Korea COVID-19 Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea COVID-19 Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia COVID-19 Diagnostic Tests Sales Value, 2019-2030
6.8.2 Southeast Asia COVID-19 Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia COVID-19 Diagnostic Tests Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India COVID-19 Diagnostic Tests Sales Value, 2019-2030
6.9.2 India COVID-19 Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
6.9.3 India COVID-19 Diagnostic Tests Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Cellex
7.1.1 Cellex Profile
7.1.2 Cellex Main Business
7.1.3 Cellex COVID-19 Diagnostic Tests Products, Services and Solutions
7.1.4 Cellex COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.1.5 Cellex Recent Developments
7.2 Abbott
7.2.1 Abbott Profile
7.2.2 Abbott Main Business
7.2.3 Abbott COVID-19 Diagnostic Tests Products, Services and Solutions
7.2.4 Abbott COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Recent Developments
7.3 Roche
7.3.1 Roche Profile
7.3.2 Roche Main Business
7.3.3 Roche COVID-19 Diagnostic Tests Products, Services and Solutions
7.3.4 Roche COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.3.5 BioMedomics Recent Developments
7.4 BioMedomics
7.4.1 BioMedomics Profile
7.4.2 BioMedomics Main Business
7.4.3 BioMedomics COVID-19 Diagnostic Tests Products, Services and Solutions
7.4.4 BioMedomics COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.4.5 BioMedomics Recent Developments
7.5 BD
7.5.1 BD Profile
7.5.2 BD Main Business
7.5.3 BD COVID-19 Diagnostic Tests Products, Services and Solutions
7.5.4 BD COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.5.5 BD Recent Developments
7.6 Henry Schein
7.6.1 Henry Schein Profile
7.6.2 Henry Schein Main Business
7.6.3 Henry Schein COVID-19 Diagnostic Tests Products, Services and Solutions
7.6.4 Henry Schein COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.6.5 Henry Schein Recent Developments
7.7 Safecare Bio-Tech
7.7.1 Safecare Bio-Tech Profile
7.7.2 Safecare Bio-Tech Main Business
7.7.3 Safecare Bio-Tech COVID-19 Diagnostic Tests Products, Services and Solutions
7.7.4 Safecare Bio-Tech COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.7.5 Safecare Bio-Tech Recent Developments
7.8 Mayo Clinic Laboratories
7.8.1 Mayo Clinic Laboratories Profile
7.8.2 Mayo Clinic Laboratories Main Business
7.8.3 Mayo Clinic Laboratories COVID-19 Diagnostic Tests Products, Services and Solutions
7.8.4 Mayo Clinic Laboratories COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.8.5 Mayo Clinic Laboratories Recent Developments
7.9 Chembio Diagnostics
7.9.1 Chembio Diagnostics Profile
7.9.2 Chembio Diagnostics Main Business
7.9.3 Chembio Diagnostics COVID-19 Diagnostic Tests Products, Services and Solutions
7.9.4 Chembio Diagnostics COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.9.5 Chembio Diagnostics Recent Developments
7.10 Mount Sinai Laboratory
7.10.1 Mount Sinai Laboratory Profile
7.10.2 Mount Sinai Laboratory Main Business
7.10.3 Mount Sinai Laboratory COVID-19 Diagnostic Tests Products, Services and Solutions
7.10.4 Mount Sinai Laboratory COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.10.5 Mount Sinai Laboratory Recent Developments
7.11 Ortho Clinical Diagnostics
7.11.1 Ortho Clinical Diagnostics Profile
7.11.2 Ortho Clinical Diagnostics Main Business
7.11.3 Ortho Clinical Diagnostics COVID-19 Diagnostic Tests Products, Services and Solutions
7.11.4 Ortho Clinical Diagnostics COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.11.5 Ortho Clinical Diagnostics Recent Developments
7.12 Zhejiang Orient Gene Biotech
7.12.1 Zhejiang Orient Gene Biotech Profile
7.12.2 Zhejiang Orient Gene Biotech Main Business
7.12.3 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Tests Products, Services and Solutions
7.12.4 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.12.5 Zhejiang Orient Gene Biotech Recent Developments
7.13 Innovita Biological Technology
7.13.1 Innovita Biological Technology Profile
7.13.2 Innovita Biological Technology Main Business
7.13.3 Innovita Biological Technology COVID-19 Diagnostic Tests Products, Services and Solutions
7.13.4 Innovita Biological Technology COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.13.5 Innovita Biological Technology Recent Developments
7.14 Guangzhou Wondfo Biotech
7.14.1 Guangzhou Wondfo Biotech Profile
7.14.2 Guangzhou Wondfo Biotech Main Business
7.14.3 Guangzhou Wondfo Biotech COVID-19 Diagnostic Tests Products, Services and Solutions
7.14.4 Guangzhou Wondfo Biotech COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.14.5 Guangzhou Wondfo Biotech Recent Developments
7.15 Guangdong Hecin-Scientific
7.15.1 Guangdong Hecin-Scientific Profile
7.15.2 Guangdong Hecin-Scientific Main Business
7.15.3 Guangdong Hecin-Scientific COVID-19 Diagnostic Tests Products, Services and Solutions
7.15.4 Guangdong Hecin-Scientific COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.15.5 Guangdong Hecin-Scientific Recent Developments
7.16 Dynamiker Biotechnology (Tianjin)
7.16.1 Dynamiker Biotechnology (Tianjin) Profile
7.16.2 Dynamiker Biotechnology (Tianjin) Main Business
7.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Tests Products, Services and Solutions
7.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments
7.17 ADVAITE
7.17.1 ADVAITE Profile
7.17.2 ADVAITE Main Business
7.17.3 ADVAITE COVID-19 Diagnostic Tests Products, Services and Solutions
7.17.4 ADVAITE COVID-19 Diagnostic Tests Revenue (US$ Million) & (2019-2024)
7.17.5 ADVAITE Recent Developments
8 Industry Chain Analysis
8.1 COVID-19 Diagnostic Tests Industrial Chain
8.2 COVID-19 Diagnostic Tests Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 COVID-19 Diagnostic Tests Sales Model
8.5.2 Sales Channel
8.5.3 COVID-19 Diagnostic Tests Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. COVID-19 Diagnostic Tests Market Trends
    Table 2. COVID-19 Diagnostic Tests Market Drivers & Opportunity
    Table 3. COVID-19 Diagnostic Tests Market Challenges
    Table 4. COVID-19 Diagnostic Tests Market Restraints
    Table 5. Global COVID-19 Diagnostic Tests Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global COVID-19 Diagnostic Tests Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies COVID-19 Diagnostic Tests Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies COVID-19 Diagnostic Tests Product Type
    Table 9. Key Companies Time to Begin Mass Production of COVID-19 Diagnostic Tests
    Table 10. Global COVID-19 Diagnostic Tests Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Diagnostic Tests as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global COVID-19 Diagnostic Tests Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global COVID-19 Diagnostic Tests Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global COVID-19 Diagnostic Tests Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global COVID-19 Diagnostic Tests Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global COVID-19 Diagnostic Tests Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global COVID-19 Diagnostic Tests Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global COVID-19 Diagnostic Tests Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global COVID-19 Diagnostic Tests Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global COVID-19 Diagnostic Tests Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global COVID-19 Diagnostic Tests Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global COVID-19 Diagnostic Tests Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global COVID-19 Diagnostic Tests Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global COVID-19 Diagnostic Tests Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global COVID-19 Diagnostic Tests Sales Value by Region (2019-2024) & (%)
    Table 27. Global COVID-19 Diagnostic Tests Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions COVID-19 Diagnostic Tests Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions COVID-19 Diagnostic Tests Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions COVID-19 Diagnostic Tests Sales Value, (2025-2030) & (US$ Million)
    Table 31. Cellex Basic Information List
    Table 32. Cellex Description and Business Overview
    Table 33. Cellex COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 34. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of Cellex (2019-2024)
    Table 35. Cellex Recent Developments
    Table 36. Abbott Basic Information List
    Table 37. Abbott Description and Business Overview
    Table 38. Abbott COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 39. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of Abbott (2019-2024)
    Table 40. Abbott Recent Developments
    Table 41. Roche Basic Information List
    Table 42. Roche Description and Business Overview
    Table 43. Roche COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 44. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of Roche (2019-2024)
    Table 45. Roche Recent Developments
    Table 46. BioMedomics Basic Information List
    Table 47. BioMedomics Description and Business Overview
    Table 48. BioMedomics COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 49. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of BioMedomics (2019-2024)
    Table 50. BioMedomics Recent Developments
    Table 51. BD Basic Information List
    Table 52. BD Description and Business Overview
    Table 53. BD COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 54. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of BD (2019-2024)
    Table 55. BD Recent Developments
    Table 56. Henry Schein Basic Information List
    Table 57. Henry Schein Description and Business Overview
    Table 58. Henry Schein COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 59. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of Henry Schein (2019-2024)
    Table 60. Henry Schein Recent Developments
    Table 61. Safecare Bio-Tech Basic Information List
    Table 62. Safecare Bio-Tech Description and Business Overview
    Table 63. Safecare Bio-Tech COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 64. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of Safecare Bio-Tech (2019-2024)
    Table 65. Safecare Bio-Tech Recent Developments
    Table 66. Mayo Clinic Laboratories Basic Information List
    Table 67. Mayo Clinic Laboratories Description and Business Overview
    Table 68. Mayo Clinic Laboratories COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 69. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of Mayo Clinic Laboratories (2019-2024)
    Table 70. Mayo Clinic Laboratories Recent Developments
    Table 71. Chembio Diagnostics Basic Information List
    Table 72. Chembio Diagnostics Description and Business Overview
    Table 73. Chembio Diagnostics COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 74. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of Chembio Diagnostics (2019-2024)
    Table 75. Chembio Diagnostics Recent Developments
    Table 76. Mount Sinai Laboratory Basic Information List
    Table 77. Mount Sinai Laboratory Description and Business Overview
    Table 78. Mount Sinai Laboratory COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 79. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of Mount Sinai Laboratory (2019-2024)
    Table 80. Mount Sinai Laboratory Recent Developments
    Table 81. Ortho Clinical Diagnostics Basic Information List
    Table 82. Ortho Clinical Diagnostics Description and Business Overview
    Table 83. Ortho Clinical Diagnostics COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 84. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of Ortho Clinical Diagnostics (2019-2024)
    Table 85. Ortho Clinical Diagnostics Recent Developments
    Table 86. Zhejiang Orient Gene Biotech Basic Information List
    Table 87. Zhejiang Orient Gene Biotech Description and Business Overview
    Table 88. Zhejiang Orient Gene Biotech COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 89. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of Zhejiang Orient Gene Biotech (2019-2024)
    Table 90. Zhejiang Orient Gene Biotech Recent Developments
    Table 91. Innovita Biological Technology Basic Information List
    Table 92. Innovita Biological Technology Description and Business Overview
    Table 93. Innovita Biological Technology COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 94. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of Innovita Biological Technology (2019-2024)
    Table 95. Innovita Biological Technology Recent Developments
    Table 96. Guangzhou Wondfo Biotech Basic Information List
    Table 97. Guangzhou Wondfo Biotech Description and Business Overview
    Table 98. Guangzhou Wondfo Biotech COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 99. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of Guangzhou Wondfo Biotech (2019-2024)
    Table 100. Guangzhou Wondfo Biotech Recent Developments
    Table 101. Guangdong Hecin-Scientific Basic Information List
    Table 102. Guangdong Hecin-Scientific Description and Business Overview
    Table 103. Guangdong Hecin-Scientific COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 104. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of Guangdong Hecin-Scientific (2019-2024)
    Table 105. Guangdong Hecin-Scientific Recent Developments
    Table 106. Dynamiker Biotechnology (Tianjin) Basic Information List
    Table 107. Dynamiker Biotechnology (Tianjin) Description and Business Overview
    Table 108. Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 109. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of Dynamiker Biotechnology (Tianjin) (2019-2024)
    Table 110. Dynamiker Biotechnology (Tianjin) Recent Developments
    Table 111. ADVAITE Basic Information List
    Table 112. ADVAITE Description and Business Overview
    Table 113. ADVAITE COVID-19 Diagnostic Tests Products, Services and Solutions
    Table 114. Revenue (US$ Million) in COVID-19 Diagnostic Tests Business of ADVAITE (2019-2024)
    Table 115. ADVAITE Recent Developments
    Table 116. Key Raw Materials Lists
    Table 117. Raw Materials Key Suppliers Lists
    Table 118. COVID-19 Diagnostic Tests Downstream Customers
    Table 119. COVID-19 Diagnostic Tests Distributors List
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
    Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. COVID-19 Diagnostic Tests Product Picture
    Figure 2. Global COVID-19 Diagnostic Tests Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global COVID-19 Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 4. COVID-19 Diagnostic Tests Report Years Considered
    Figure 5. Global COVID-19 Diagnostic Tests Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by COVID-19 Diagnostic Tests Revenue in 2023
    Figure 7. COVID-19 Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Rapid Diagnostic Test (RDT) Picture
    Figure 9. Enzyme Linked Immunosorbent Assay (ELISA) Picture
    Figure 10. Neutralization Assay Picture
    Figure 11. Global COVID-19 Diagnostic Tests Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global COVID-19 Diagnostic Tests Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Home
    Figure 14. Product Picture of Hospital
    Figure 15. Product Picture of Clinical
    Figure 16. Global COVID-19 Diagnostic Tests Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global COVID-19 Diagnostic Tests Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America COVID-19 Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America COVID-19 Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe COVID-19 Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe COVID-19 Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific COVID-19 Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific COVID-19 Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America COVID-19 Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America COVID-19 Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa COVID-19 Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa COVID-19 Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions COVID-19 Diagnostic Tests Sales Value (%), (2019-2030)
    Figure 29. United States COVID-19 Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States COVID-19 Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States COVID-19 Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe COVID-19 Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe COVID-19 Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe COVID-19 Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 35. China COVID-19 Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China COVID-19 Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 37. China COVID-19 Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan COVID-19 Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan COVID-19 Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan COVID-19 Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea COVID-19 Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea COVID-19 Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea COVID-19 Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia COVID-19 Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia COVID-19 Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia COVID-19 Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 47. India COVID-19 Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India COVID-19 Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 49. India COVID-19 Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 50. COVID-19 Diagnostic Tests Industrial Chain
    Figure 51. COVID-19 Diagnostic Tests Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

RELATED REPORTS

Global Robotics Paint Booth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3R7922
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Civil Engineering Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20Y6111
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Humanoid Robot Bearings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12J17457
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global CAD in Industrial Machinery Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32J5952
Fri Sep 12 00:00:00 UTC 2025

Add to Cart